Role of microRNAs in endothelial progenitor cells: Implication for cardiac repair

Journal of Stem Cells

Volumn 9, Issue 2, 2014, Pages 107-115

  Goretti, E ^a   Wagner, D R ^a,b   Devaux, Y ^a  

^a Public Research Centre for Health   (Luxembourg)

^b Centre Hospitalier   (Luxembourg)

Author keywords

Angiogenesis; Cardiac repair; Cardiovascular diseases; Endothelial progenitor cell; MicroRNAs

Indexed keywords

MICRORNA; MICRORNA 107; MICRORNA 10A; MICRORNA 126; MICRORNA 150; MICRORNA 15A; MICRORNA 16; MICRORNA 21; MICRORNA 210; MICRORNA 221; MICRORNA 222; MICRORNA 31; MICRORNA 34A; UNCLASSIFIED DRUG;

ARTICLE; CARDIOVASCULAR DISEASE; ENDOTHELIAL PROGENITOR CELL; GENE FUNCTION; HEART FUNCTION; HEART SURGERY; HUMAN; MALIGNANT NEOPLASM; MEMBRANE MICROPARTICLE; NONHUMAN; SENESCENCE; ANIMAL; CYTOLOGY; HEART DISEASES; METABOLISM;

ANIMALS; ENDOTHELIAL PROGENITOR CELLS; HEART DISEASES; HUMANS; MICRORNAS;

EID: 84922480421     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Lee RC, Feinbaum RL, Ambros V. The c. Elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14. Cell, 1993 75, 843-854.
2. Bartel DP. Micrornas: Genomics, biogenesis, mechanism, and function. Cell, 2004 116,281-297.
3. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science, 1997 275, 964-967.
4. Fadini GP, Losordo D, Dimmeler S. Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res, 2012 110, 624-637.
5. Siddique A, Shantsila E, Lip GY, Varma C. Endothelial progenitor cells: What use for the cardiologist? J Angiogenes Res, 2010 2,6.
6. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell-based therapy in ischaemic heart disease: Promise, uncertainties, and challenges. Eur Heart J, 2011 32, 1197-1206.
7. van Rooij E, Olson EN. Microrna therapeutics for cardiovascular disease: Opportunities and obstacles. Nature reviews. Drug Discov, 2012 11,860-872.
8. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating micrornas as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008 105,10513-10518.
9. Vickers KC, Palmisano BT, Shoucri BM, Shamburek RD, Remaley AT. Micrornas are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature Cell Biol, 2011 13,423-433.
10. Montecalvo A, Larregina AT, Shufesky WJ, Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z, Milosevic J, Tkacheva OA, Divito SJ, Jordan R, Lyons-Weiler J, Watkins SC, Morelli AE. Mechanism of transfer of functional micrornas between mouse dendritic cells via exosomes. Blood, 2012 119,756-766.
11. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G, Capogrossi MC. Circulating micrornas are new and sensitive biomarkers of myocardial infarction. Eur Heart J, 2010 31,2765-2773.
12. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S, Schroen B. Circulating microrna-208b and microrna-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet, 2010 3,499-506.
13. Devaux Y, Vausort M, Goretti E, Nazarov PV, Azuaje F, Gilson G, Corsten MF, Schroen B, Lair ML, Heymans S, Wagner DR. Use of circulating micrornas to diagnose acute myocardial infarction. Clin Chem, 2012 58,559-567.
14. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC, Thum T. Diagnostic and prognostic impact of six circulating micrornas in acute coronary syndrome. J Mol Cell Cardiol, 2011 51,872-875.
15. Eulalio A, Mano M, Dal Ferro M, Zentilin L, Sinagra G, Zacchigna S, Giacca M. Functional screening identifies mirnas inducing cardiac regeneration. Nature, 2012 492,376-381.
16. Bernardo BC, Gao X-M, Winbanks CE, Boey EJH, Tham YK, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du X-J, Lin RCY, McMullen JR. Therapeutic inhibition of the mir-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci USA, 2012 109,17615-17620.
17. Janssen HL, Reesink HW, Lawitz EJ, Zeuzem S, Rodriguez-Torres M, Patel K, van der Meer AJ, Patick AK, Chen A, Zhou Y, Persson R, King BD, Kauppinen S, Levin AA, Hodges MR. Treatment of hcv infection by targeting microrna. New Engl J Med, 2013, March 27.
18. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol, 2004 24,288-293.
19. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, Oh IY, Kim TY, Cho HJ, Kang HJ, Chae IH, Yang HK, Oh BH, Park YB, Kim HS. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: The role of angiogenic cytokines and matrix metalloproteinases. Circulation, 2005 112,1618-1627.
20. Fadini GP, Agostini C, Avogaro A. Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis, 2010 209,10-17.
21. Rolland-Turner M, Goretti E, Bousquenaud M, Leonard F, Nicolas C, Zhang L, Maskali F, Marie PY, Devaux Y, Wagner D. Adenosine stimulates the migration of human endothelial progenitor cells. Role of cxcr4 and microrna-150. PLoS ONE, 2013 8,e54135.
22. Oh BJ, Kim DK, Kim BJ, Yoon KS, Park SG, Park KS, Lee MS, Kim KW, Kim JH. Differences in donor cxcr4 expression levels are correlated with functional capacity and therapeutic outcome of angiogenic treatment with endothelial colony forming cells. Biochem Biophys Res Commun, 2010 398,627-633.
23. Heinrich EM, Dimmeler S. Micrornas and stem cells: Control of pluripotency, reprogramming, and lineage commitment. Circ Res, 2012 110,1014-1022.
24. Goretti E, Rolland-Turner M, Léonard F, Zhang L, Wagner DR, Devaux Y. Microrna-16 affects key functions of human endothelial progenitor cells. J Leukoc Biol, 2013 93,645-655.
25. Spinetti G, Fortunato O, Caporali A, Shantikumar S, Marchetti M, Meloni M, Descamps B, Floris I, Sangalli E, Vono R, Faglia E, Specchia C, Pintus G, Madeddu P, Emanueli C. Microrna-15a and microrna-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ Res, 2013 112,335-346.
26. Fleissner F, Jazbutyte V, Fiedler J, Gupta SK, Yin X, Xu Q, Galuppo P, Kneitz S, Mayr M, Ertl G, Bauersachs J, Thum T. Asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microrna-21-dependent mechanism. Circ Res, 2010 107,138-143.
27. Meng S, Cao J, Wang L, Zhou Q, Li Y, Shen C, Zhang X, Wang C. Microrna 107 partly inhibits endothelial progenitor cells differentiation via hif-1beta. PLoS ONE, 2012 7,e40323.
28. Tano N, Kim HW, Ashraf M. Microrna-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting cxcr4. PLoS ONE, 2011 6,e23114.
29. Devaux Y, Vausort M, McCann GP, Zangrando J, Kelly D, Razvi N, Zhang L, Ng LL, Wagner DR, Squire IB. Microrna-150: A novel marker of left ventricular remodeling after acute myocardial infarction. Circ Cardiovasc Genet, 2013 April 1.
30. Minami Y, Satoh M, Maesawa C, Takahashi Y, Tabuchi T, Itoh T, Nakamura M. Effect of atorvastatin on microrna 221/222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. Eur J Clin Invest, 2009 39,359-367.
31. Zhang X, Mao H, Chen JY, Wen S, Li D, Ye M, Lv Z. Increased expression of microrna-221 inhibits pak1 in endothelial progenitor cells and impairs its function via c-raf/mek/erk pathway. Biochem Biophys Res Commun, 2013 431,404-408.
32. Zhao T, Li J, Chen AF. Microrna-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab, 2010 299,E110-116.
33. Zhu S, Deng S, Ma Q, Zhang T, Jia C, Zhuo D, Yang F, Wei J, Wang L, Dykxhoorn DM, Hare JM, Goldschmidt-Clermont PJ, Dong C. Microrna-10a* and microrna-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group a2. Circ Res, 2013 112,152-164.
34. Cheng CC, Lo HH, Huang TS, Cheng YC, Chang ST, Chang SJ, Wang HW. Genetic module and mirnome trait analyses reflect the distinct biological features of endothelial progenitor cells from different anatomic locations. BMC genomics, 2012 13,447.
35. Zhang Q, Kandic I, Kutryk MJ. Dysregulation of angiogenesis-related micrornas in endothelial progenitor cells from patients with coronary artery disease. Biochem Biophys Res Commun, 2011 405,42-46.
36. Qiang L, Hong L, Ningfu W, Huaihong C, Jing W. Expression of mir-126 and mir-508-5p in endothelial progenitor cells is associated with the prognosis of chronic heart failure patients. Int J Cardiol, 2013, Feb 25.
37. Jakob P, Doerries C, Briand S, Mocharla P, Krankel N, Besler C, Mueller M, Manes C, Templin C, Baltes C, Rudin M, Adams H, Wolfrum M, Noll G, Ruschitzka F, Luscher TF, Landmesser U. Loss of angiomir-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: Role for impaired in vivo neovascularization and cardiac repair capacity. Circulation, 2012 126,2962-2975.
38. van Solingen C, de Boer HC, Bijkerk R, Monge M, van Oeveren-Rietdijk AM, Seghers L, de Vries MR, van der Veer EP, Quax PH, Rabelink TJ, van Zonneveld AJ. Microrna-126 modulates endothelial sdf-1 expression and mobilization of sca-1(+)/lin(-) progenitor cells in ischaemia. Cardiovasc Res, 2011 92,449-455.
39. Mocharla P, Briand S, Giannotti G, Dorries C, Jakob P, Paneni F, Luscher T, Landmesser U. Angiomir-126 expression and secretion from circulating cd34(+) and cd14(+) pbmcs: Role for proangiogenic effects and alterations in type 2 diabetics. Blood, 2013 121,226-236.
40. Alaiti MA, Ishikawa M, Masuda H, Simon DI, Jain MK, Asahara T, Costa MA. Up-regulation of mir-210 by vascular endothelial growth factor in ex vivo expanded cd34+ cells enhances cell-mediated angiogenesis. J Cell Mol Med, 2012 16,2413-2421.
41. Plummer PN, Freeman R, Taft RJ, Vider J, Sax M, Umer BA, Gao D, Johns C, Mattick JS, Wilton SD, Ferro V, McMillan NA, Swarbrick A, Mittal V, Mellick AS. Micrornas regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res, 2013 73,341-352.
42. Cantaluppi V, Biancone L, Figliolini F, Beltramo S, Medica D, Deregibus MC, Galimi F, Romagnoli R, Salizzoni M, Tetta C, Segoloni GP, Camussi G. Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant, 2012 21,1305-1320.
43. Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, Sordi A, Biancone L, Tetta C, Camussi G. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microrna-dependent reprogramming of resident renal cells. Kidney Int, 2012 82,412-427.
44. Ranghino A, Cantaluppi V, Grange C, Vitillo L, Fop F, Biancone L, Deregibus MC, Tetta C, Segoloni GP, Camussi G. Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol, 2012 25,75-85.